Morphotonics
Series B in 2024
Morphotonics specializes in developing and applying nano- and micro-imprint structures directly onto large rigid and flexible surfaces. They offer roll-to-plate nanoimprinting services, along with equipment, materials, stamps, and samples to facilitate the production of advanced materials and devices.
RiboPro
Convertible Note in 2024
RiboPro is a biotechnology company that develops RNA-based products for research tools and therapeutics, leveraging proprietary technologies such as de-immunization of mRNA, expression boosting and libraries extension, and novel lipid nanoparticle formulations for RNA delivery to a variety of tissues. The company focuses on molecular biology applications, supports clinical trials, and offers health diagnostic services through its RNA platforms.
SCIL Nanoimprint Solutions
Seed Round in 2023
SCIL specializes in nanoimprint lithography technology, offering systems to pattern nanostructures on large wafers. Its innovative method combines the precision of rigid stamps with the flexibility of soft stamp methods, enabling manufacturers of optics and photonic products to achieve high-volume production at lower costs.
Vivolta specializes in contract development and manufacturing of electrospun medical products. It offers nanofiber-based solutions designed to guide the human body's natural healing processes.
LeydenJar Technologies
Venture Round in 2021
Founded in 2016 and headquartered in Leiden, Netherlands, LeydenJar Technologies specializes in enhancing lithium-ion battery performance by replacing traditional graphite anodes with nanoporous, pure silicon anodes. This innovation results in batteries that are cheaper (-20%), greener (-85% CO2 footprint), and have higher energy density (+70%).
RiboPro
Seed Round in 2021
RiboPro is a biotechnology company that develops RNA-based products for research tools and therapeutics, leveraging proprietary technologies such as de-immunization of mRNA, expression boosting and libraries extension, and novel lipid nanoparticle formulations for RNA delivery to a variety of tissues. The company focuses on molecular biology applications, supports clinical trials, and offers health diagnostic services through its RNA platforms.
LeydenJar Technologies
Seed Round in 2018
Founded in 2016 and headquartered in Leiden, Netherlands, LeydenJar Technologies specializes in enhancing lithium-ion battery performance by replacing traditional graphite anodes with nanoporous, pure silicon anodes. This innovation results in batteries that are cheaper (-20%), greener (-85% CO2 footprint), and have higher energy density (+70%).
LeydenJar Technologies
Seed Round in 2018
Founded in 2016 and headquartered in Leiden, Netherlands, LeydenJar Technologies specializes in enhancing lithium-ion battery performance by replacing traditional graphite anodes with nanoporous, pure silicon anodes. This innovation results in batteries that are cheaper (-20%), greener (-85% CO2 footprint), and have higher energy density (+70%).
Cristal Therapeutics
Venture Round in 2017
Cristal Therapeutics BV, established in 2011 and headquartered in Maastricht, the Netherlands, operates as a clinical-stage pharmaceutical company specializing in nanomedicine development. The company's core business revolves around its proprietary CriPec platform, which transforms drugs into nanoparticles for targeted delivery. Cristal Therapeutics focuses on treating diseases such as cancer by improving drug efficacy and safety profiles through this innovative technology.
Vivolta
Venture Round in 2012
Vivolta specializes in contract development and manufacturing of electrospun medical products. It offers nanofiber-based solutions designed to guide the human body's natural healing processes.
Mutracx
Venture Round in 2010
Mutracx is a specialized manufacturer of digital inner layer printers, primarily focused on the industrial printed circuit board sector. Established as an independent entity in 2009 following its spin-out from Océ’s Inkjet Application Centre in Eindhoven, The Netherlands, Mutracx has developed the Lunaris printer, which utilizes advanced inkjet technology to print the inner, outer, and solder mask layers of printed circuit boards. This innovation allows customers to achieve superior quality and efficiency in their printing processes, offering a faster and more cost-effective solution. Mutracx collaborates closely with development partners in South East Netherlands, an area recognized for its expertise in mechatronics and nanometre applications. The company’s commitment to innovation has been acknowledged through the receipt of the largest PiD subsidy from the Dutch Government, reflecting its pivotal role in advancing high-end design solutions in the graphics arts arena.